We are live on ! Find out more
IRD

Opus Genetics
IRD

35 hedge funds and large institutions have $10.1M invested in Opus Genetics in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

41% more capital invested

Capital invested by funds: $7.15M → $10.1M (+$2.91M)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3% less funds holding

Funds holding: 36 → 35 (-1)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$196K
2
Citadel Advisors
Citadel Advisors
Florida
+$38.4K
3
CL
CSS LLC
Illinois
+$35.3K
4
UBS Group
UBS Group
Switzerland
+$28.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$14.6K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.21M
2
Millennium Management
Millennium Management
New York
-$8K
3
ASN
Advisory Services Network
Georgia
-$6.45K
4
TSS
Two Sigma Securities
New York
-$5K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
-$2.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
CL
1
CSS LLC
Illinois
$5.21M +$35.3K +252 New
SM
2
Sabby Management
Florida
$2.28M -$1.21M -8,628 -31%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.23M +$14.6K +104 +1%
Renaissance Technologies
4
Renaissance Technologies
New York
$592K +$196K +1,395 +40%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$230K – – –
BIT
6
BlackRock Institutional Trust
California
$84K – – –
Northern Trust
7
Northern Trust
Illinois
$53K – – –
HVIA
8
Hudson Valley Investment Advisors
New York
$50K – – –
VKH
9
Virtu KCG Holdings
New York
$45K +$6.17K +44 +13%
NFC
10
Northeast Financial Consultants
Connecticut
$38K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$37K – – –
CCM
12
Condor Capital Management
New Jersey
$36K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$33K +$38.4K +274 New
UBS Group
14
UBS Group
Switzerland
$27K +$28.3K +202 +962%
BMC
15
Benin Management Corp
Connecticut
$21K – – –
GC
16
Guggenheim Capital
Illinois
$17K – – –
Goldman Sachs
17
Goldman Sachs
New York
$12K – – –
BA
18
BlackRock Advisors
Delaware
$11K – – –
State Street
19
State Street
Massachusetts
$10K – – –
BFA
20
BlackRock Fund Advisors
California
$10K +$841 +6 +8%
Cambridge Investment Research Advisors
21
Cambridge Investment Research Advisors
Iowa
$9K – – –
Bank of America
22
Bank of America
North Carolina
$6K +$4.34K +31 +182%
ICOA
23
Investment Centers of America
North Dakota
$5K +$2.1K +15 +71%
NPT
24
Nixon Peabody Trust
Massachusetts
$3K – – –
TRCT
25
Tower Research Capital (TRC)
New York
$3K +$2.8K +20 +286%
1
2

IRD Hedge Fund Activity: Q2 2016 in Review

35 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2016, worth a combined $10.1M — up 41% from $7.15M a quarter earlier.

Fund positioning in IRD was balanced in Q2 2016: 2 funds opened new positions, 2 closed out, 9 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $196K. The largest seller was Sabby Management, cutting an estimated $1.21M.

  • 35 institutional investors held Opus Genetics (IRD) as of Q2 2016, down from 36 in Q1 2016.
  • Funds reported $10.1M of Opus Genetics stock for Q2 2016, up 41% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q2 2016 and 2 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q2 2016 was Renaissance Technologies, an estimated $196K added.
  • The largest Opus Genetics seller in Q2 2016 was Sabby Management, an estimated $1.21M sold.

Based on aggregated 13F filings for Q2 2016.